These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4091871)

  • 1. Pharmacodynamics and pharmacokinetics of the basic triamterene analogue dimethylaminohydroxypropoxytriamterene.
    Priewer H; Kraft H; Mutschler E
    Arzneimittelforschung; 1985; 35(11):1688-91. PubMed ID: 4091871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, natriuretic, antikaliuretic and antimagnesiuretic properties of an acidic triamterene derivative.
    Netzer T; Ullrich F; Majewski M; Mutschler E
    Arzneimittelforschung; 1992 Jun; 42(6):807-11. PubMed ID: 1418034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamics of acidic triamterene derivatives and their esters and amides.
    Priewer H; Kraft H; Mutschler E
    Arzneimittelforschung; 1985; 35(10):1544-7. PubMed ID: 4074412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamics of straight-chain and branched-chain acidic triamterene derivatives.
    Priewer H; Kraft H; Mutschler E
    Arzneimittelforschung; 1986 Feb; 36(2):213-5. PubMed ID: 3964327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of triamterene and hydroxytriamterene sulfuric acid ester on diuresis and saluresis in rats after oral and intravenous application.
    Leilich G; Knauf H; Mutschler E; Völger KD
    Arzneimittelforschung; 1980; 30(6):949-53. PubMed ID: 7191270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of triamterene and hydrochlorothiazide and their combination in healthy volunteers.
    Möhrke W; Knauf H; Mutschler E
    Int J Clin Pharmacol Ther; 1997 Oct; 35(10):447-52. PubMed ID: 9352394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies with triamterene derivatives for oral application.
    Priewer H; Kraft H; Mutschler E
    Arzneimittelforschung; 1985; 35(12):1819-21. PubMed ID: 4096735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a new pteridine derivative on urinary sodium, potassium and magnesium excretion in conscious saline-loaded rats.
    Netzer T; Ullrich F; Priewer H; Majewski M; Mutschler E
    Br J Pharmacol; 1992 May; 106(1):222-6. PubMed ID: 1504728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorimetric determination of dimethylaminohydroxypropoxytriamterene in biological fluids by direct evaluation of thin-layer chromatograms.
    Kraft H; Mutschler E
    Arzneimittelforschung; 1985; 35(10):1542-4. PubMed ID: 4074411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Saluretic and diuretic effects of xipamide-triamterene combinations in varying dose ratios in rats].
    Armah B; Dies R; Heinz N
    Arzneimittelforschung; 1983; 33(1):131-5. PubMed ID: 6681965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Animal experimental and human pharmacologic studies with phase-II metabolites of triamterene].
    Völger KD
    Arzneimittelforschung; 1991 May; 41(5):499-506. PubMed ID: 1898420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and pharmacodynamic study of the combination of furosemide retard and triamterene.
    Loew D; Barkow D; Schuster O; Knoell HE
    Eur J Clin Pharmacol; 1984; 26(2):191-5. PubMed ID: 6723757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An experimental and clinical pharmacological study of the influence of triamterene on the diuretic and saluretic properties of furosemide xantinol].
    Celdrán E; Bekett PR; Roberts DJ
    Arzneimittelforschung; 1976; 26(11):2073-6. PubMed ID: 14648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamics and pharmacokinetics of furosemide-retard and furosemide-retard/triamterene.
    Heimsoth V; Loew D; Schuster O
    Eur J Drug Metab Pharmacokinet; 1988; 13(3):161-4. PubMed ID: 3240762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics of xipamide and triamterene in healthy probands].
    Diembeck W; Dies R; Heinz N
    Arzneimittelforschung; 1982; 32(11):1482-5. PubMed ID: 6891256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary elimination kinetics and diuretic effect of intravenous furosemide in nephrotic children.
    Prandota J
    Dev Pharmacol Ther; 1982; 5(1-2):98-108. PubMed ID: 7151641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for an acute antimagnesiuretic effect of triamterene derivatives.
    Priewer H; Kraft H; Mutschler E
    Pharm Res; 1985 Mar; 2(2):90-3. PubMed ID: 24272618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics and dynamics of triamterene at steady-state in patients with cirrhosis.
    Dao MT; Villeneuve JP
    Clin Invest Med; 1988 Feb; 11(1):6-9. PubMed ID: 3365882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diuretic and saluretic effects of bemetizide and triamterene compared to those of their combination (author's transl)].
    Neumann D; Schmidt G
    Arzneimittelforschung; 1977; 27(3):559-62. PubMed ID: 577422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of xipamide and triamterene - alone or in combination - on electrolyte excretion in the rat.
    Hohenegger M; Holzer F
    Int J Clin Pharmacol Biopharm; 1976 Jun; 13(4):298-303. PubMed ID: 965134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.